FDA Adverse Event Injury Summary report: N

UNK-CV-SR

MDR report key: 13541107 · Received February 16, 2022

Report

Report Number
9612164-2022-00635
Event Type
Injury
Date Received
February 16, 2022
Date of Event
June 18, 2021
Report Date
February 16, 2022
Manufacturer
MEDTRONIC IRELAND
Product Code
MIH
PMA / PMN Number
P100021
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SC, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

MEDTRONIC RECEIVED THE FOLLOWING INFORMATION FROM A JOURNAL ARTICLE ENTITLED; LASER IN SITU FENESTRATION IN THORACIC ENDOVASCULAR AORTIC REPAIR: A SINGLE-CENTER ANALYSIS EVANS ET AL, ANN VASC SURG 2021; 76: 159¿167 HTTPS://DOI.ORG/10.1016/J.AVSG.2021.05.006: MEAN AGE, MEAN GENDER, AND EXACT DATE OF IMPLANT UNKNOWN. THERE WAS NO INFORMATION TO SUGGEST ANY MEDTRONIC DEVICE FAILURE CAUSED OR CONTRIBUTED TO A DEATH. DEATHS ARE COMMON OCCURRENCES HOWEVER THE CAUSE(S) OF DEATH ARE OFTEN NOT CHARACTERIZED OR CLEARLY ASSOCIATED WITH A PARTICULAR PRODUCT. THEREFORE, DEATHS WILL NOT BE CONSIDERED REPORTABLE AS MDR OR VIGILANCE UNLESS CLEARLY STATED AS BEING ASSOCIATED WITH MEDTRONIC PRODUCT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 0

UNKNOWN MEDTRONIC STENT GRAFTS WERE IMPLANTED IN PATIENTS DURING THE ENDOVASCULAR TEVAR WITH LASER IN SITU FENESTRATION (LISF) ON UNKNOWN DATES. NON MDT STENT GRAFTS WERE ALSO IMPLANTED. THE FOLLOWING ADVERSE EVENTS WERE REPORTED: BYPASS STENOSIS STROKE, SPINAL CORD ISCHEMIA, ACCESS SITE HEMATOMA, ARRHYTHMIAS, AKI, PNEUMONIA, THORACIC DUCT INJURY, MI, REINTERVENTION AND DEATH. THERE WAS NO INFORMATION TO SUGGEST ANY MEDTRONIC DEVICE FAILURE CAUSED OR CONTRIBUTED TO A DEATH. THE CAUSE OF THE ADVERSEEVENTS ARE UNDETERMINED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
8759 UNK-CV-SR SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR MIH MEDTRONIC IRELAND UNK-CV-SR

Patients

Seq Age Sex Outcome Treatment
1 62 YR Male Required Intervention